|
|||||
|
|
T1-Tumoren |
|
| Authors: | Prof Dr M Flentje J Pfannschmidt C Rübe E Stoelben |
| Institution: | 1. Klinik und Poliklinik f. Strahlentherapie, Klinikum der Universit?t Würzburg, Josef-Schneider-Stra?e 11, 97070, Würzburg, Deutschland 2. Klinik für Thoraxchirurgie, HELIOS Klinikum Emil von Behring, Berlin, Deutschland 3. Klinik für Strahlentherapie und Radioonkologie, Universit?tsklinikum des Saarlandes, Homburg/Saar, Deutschland 4. Lungenklinik K?ln Merheim, K?ln, Deutschland |
| Abstract: | ContextLocal tumor control in stage I non-small cell lung cancer (NSCLC) will cure many patients. Risk-adapted screening procedures will probably increase the frequency of earlier tumor stages.MethodeResearch and analysis of the current literature and clinical trials.ResultsAdvanced age and comorbidities, however, complicate treatment in this patient population. Both surgery and stereotactic ablative radiotherapy (SART) provide similar rates of local efficacy in early stage lung cancer. The curative potential of an oncological radical tumor resection has been documented for many years. In clearly operable patients the advantage of complete histological staging, definitive removal and risk estimate for adjuvant treatment have been confirmed. The SART is less invasive and also offers definitive treatment for frail patients.ConclusionPresently, interdisciplinary counselling with consideration of age, comorbidities and patient preference seems mandatory for optimal patient care. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |